Advanced Search

 

Study ID Status Title Patient Level Data
111572 Completed Challenge dose administration of Twinrix™ or comparator 4 years after primary vaccination. Study Listed on ClinicalStudyDataRequest.com
111580 Completed A single blind, randomized, cross-over study to compare the oral disposition of levocetirizine when given alone (5mg) or as the racemate (cetirizine 10mg), and parallel study to investigate the safety and tolerability and the pharmacokinetics of levocetirizine and cetirizine, following
111582 Completed An Open Label Study to Examine the Effects of Low-Fat and High-Fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients
111587 Completed A healthy volunteer repeat dose study to evaluate; the safety, tolerability, pharmacokinetics, effects on the pharmacokinetics of midazolam and the neurokinin 1 receptor occupancy of GSK1144814
111592 Completed Assessment of the Anti-Inflammatory activity, efficacy and safety of Intravenous SB-681323 in subjects at risk for development of Acute Lung Injury (ALI) or Acute Respiratory Distress Syndrome (ARDS). Study Listed on ClinicalStudyDataRequest.com
111596 Completed A study in healthy volunteers of single doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound alone and when co-administered with sitagliptin Study Listed on ClinicalStudyDataRequest.com
111598 Completed A study in type 2 diabetic subjects of single and multiple doses of orally administered GSK1292263 to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of the compound Study Listed on ClinicalStudyDataRequest.com
111601 Terminated A randomized, placebo-controlled, single-blind study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of otelixizumab in rheumatoid arthritis subjects Study Listed on ClinicalStudyDataRequest.com
111602 Completed A Phase I, open label, randomized, four-period crossover studyto evaluate the effects of Maalox® Advanced Maximum Strengthand One A Day® Maximum on pharmacokinetics of GSK1349572in healthy adult subjects
111603 Completed A Phase I, open label, two period, single fixed-sequence crossover study to evaluate the effect of etravirine on GSK1349572 pharmacokinetics in healthy adult subjects (ING111603)
111604 Completed A Phase I, Open Label, Single Sequence,Drug Interaction Study Evaluating Plasma GSK1349572 and Tenofovir Pharmacokinetics in Healthy Adult Subjects (ING111604)
111610 Completed A randomized, double-blind, placebo-controlled study in healthy volunteers to examine the safety, tolerability and pharmacokinetics of a) single, ascending and b) twice-daily repeat doses of intranasal SB-705498 Study Listed on ClinicalStudyDataRequest.com
111611 Completed A randomised, double-blind, placebo-controlled study to assess the effect of oral, single dose SB-705498 in a validated intranasal capsaicin challenge model in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
111626 Completed A trial to evaluate the immunogenicity of accelerated primary vaccination with monovalent A/Indonesia/5/05 (H5N1) vaccine antigen in association with AS03 adjuvant in adults aged 18-64 Study Listed on ClinicalStudyDataRequest.com
111631 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in people aged 18 years or above Study Listed on ClinicalStudyDataRequest.com
111634 Completed Primary and booster vaccination course in human immunodeficiency virus (HIV) infected infants, HIV exposed uninfected infants and unexposed uninfected infants receiving the pneumococcal vaccine GSK 1024850A.
111635 Completed Clinical study in children, 6 months to 3 years of age, to assess the immunogenicity and safety of two dose levels of thimerosal-free Fluviral® vaccine, using a licensed influenza virus vaccine, Vaxigrip® as the control Study Listed on ClinicalStudyDataRequest.com
111645 Completed A Phase 1/2, Open-Label, Multicenter Study of GSK1363089Gin Adult Subjects with Hepatocellular Carcinoma
111649 Completed A randomised, double-blind study in healthy volunteers to compare the properties and characteristics of an investigational formulation of lamotrigine with placebo Study Listed on ClinicalStudyDataRequest.com
111651 Completed A study to evaluate GSK Biologicals’ candidate formulations of pneumococcal vaccines (GSK2189242A) in young adults. Study Listed on ClinicalStudyDataRequest.com
111652 Completed A study to evaluate GSK Biologicals’ candidate formulations of pneumococcal vaccines (GSK2189241A) in elderly subjects. Study Listed on ClinicalStudyDataRequest.com
111654 Completed Non-inferiority of a commercial lot of the pneumococcal vaccine GSK1024850A compared to a clinical lot. Study Listed on ClinicalStudyDataRequest.com
111662 Completed A fixed dose, dose response study for ropinirole prolonged release (PR) in patients with early stage Parkinson's Disease Study Listed on ClinicalStudyDataRequest.com
111664 Completed Reactogenicity and safety of two doses of GSK Biologicals’ oral live attenuated human rotavirus vaccine, Rotarix™ when administered in Sri Lankan infants aged at least 6 weeks at the time of first vaccination.
111670 Completed Long-term antibody persistence of GSK Biologicals' MenACWY-TT vaccine versus Menactra® in healthy adolescents/adults aged 10-25 years and booster response to MenACWY-TT vaccine administered at 5 years post-primary vaccination

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.